Korro Bio (KRRO): 10% owner bought ~$295K
Lynx1 Capital Management LP, 10% owner at Korro Bio, bought ~$295K of Korro Bio shares.
- ~$295K
- Approx. value · 25K sh @ $11.75
- 1.62M
- Holds after · shares reported
- Traded
- Oct 26, 2026
- Filed
- Oct 26, 2026
Context
Written by software from the filings listed below · Oct 26, 2026
- What was filed. SEC Form 4 reports Lynx1 Capital Management LP, a 10% owner, bought 25,124 Korro Bio (KRRO) shares at $11.75 each in an open-market purchase, about $295K. The shares are held indirectly.
4 more points, with the facts they come from, are in OQRO Pro.
Sign up freeThe story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 22, 2026Insider · 1 personInsiders: 2 purchases (~$559K)
- Oct 23, 2026Insider · Bought outside the usual window10% owner purchased ~$30K of KRRO shares in the open market
- Oct 26, 2026 · this disclosureInsider · Bought outside the usual window10% owner purchased ~$295K of KRRO shares in the open market
What came next
- Oct 27, 20265% stakeBlackRock, Inc. reported a passive stake (13G) of 4.9%
- Nov 3, 2026Company filing · Form 8-K · Agreement ended, ResultsEnded an important agreement, and reported its results
- Nov 11, 2026Insider · 1 personInsiders: 4 sales (~$401K)
- Nov 12, 20265% stakeAdage Capital Management, L.P. reported a passive stake (13G) of 6.8%
- Nov 12, 2026Insider · 1 personInsiders: 2 sales (~$573K)
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Korro Bio
For Korro Bio, OQRO holds 12 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its KRRO page.
Other recent filings by Lynx1 Capital Management LP, 10% owner
- SEC Form 4 at Korro Bio (KRRO)Oct 26, 2026
- SEC Form 4 at Korro Bio (KRRO)Oct 26, 2026
- SEC Form 4 at Korro Bio (KRRO)Oct 26, 2026
- SEC Form 4 at Passage Bio (PASG)Jun 30, 2026
- SEC Form 4 at Tscan Therapeutics (TCRX)Dec 23, 2025
The full history of Lynx1 Capital Management LP, 10% owner is on the profile page.
How this filing works
Explore the data
Other disclosures at Korro Bio
- SEC Form 4Nov 13, 2026
- SEC Form 4Nov 13, 2026
- SEC Form 4Nov 13, 2026
- SEC Form 4Nov 13, 2026
- SEC Form 4Nov 13, 2026
- SEC Form 4Nov 13, 2026
Everything OQRO holds on this company is on its KRRO page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
